Pre-emptive oral ganciclovir can reduce the risk of cytomegalovirus disease in liver transplant recipients J. Torre-Cisneros, J.A. Madueño, C. Herrero, M. de la Mata, R. Gonzalez, A. Rivero, G. Miño, P. Sánchez-Guijo Clinical Microbiology and Infection Volume 8, Issue 12, Pages 773-780 (December 2002) DOI: 10.1046/j.1469-0691.2002.00510.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions
Figure 1 Trial profile. Clinical Microbiology and Infection 2002 8, 773-780DOI: (10.1046/j.1469-0691.2002.00510.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions